Johnson & Johnson
Johnson & Johnson reported 15 stocks worth $762M in its 13F filing for Q3 2026, filed Oct 26, 2026. Its largest holdings are PTGX (45.3%), NBTX (23.0%) and MGTX (9.6%). Compared with Q2 2026, the fund added to CBRS.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  PTGX Protagonist Therapeutics Inc | $345M | 45.3% | 2.4M | No change | 8 of 8 | |
| 2 |  NBTX Nanobiotix | $175M | 23.0% | 5.6M | No change | 8 of 8 | |
| 3 |  MGTX Meiragtx Hldgs PLC | $73.1M | 9.6% | 6.6M | No change | 8 of 8 | |
| 4 |  RAPP Rapport Therapeutics Inc | $60M | 7.9% | 1.8M | No change | 8 of 8 | |
| 5 |  CTNM Contineum Therapeutics Inc | $26.6M | 3.5% | 2M | No change | 8 of 8 | |
| 6 |  CBRS Cerebras Systems Inc Com CL A | $22.9M | 3.0% | 129K | +75K (+140%) | 2 of 8 | |
| 7 |  XNCR Xencor Inc | $18.7M | 2.5% | 748K | No change | 8 of 8 | |
| 8 |  LEGN Legend Biotech Corp | $16.2M | 2.1% | 815K | No change | 8 of 8 | |
| 9 |  FATE Fate Therapeutics Inc | $8M | 1.1% | 3.4M | No change | 8 of 8 | |
| 10 |  CVRX Cvrx Inc | $7M | 0.9% | 4M | No change | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 26, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Johnson & Johnson 13F FAQ
What does Johnson & Johnson own?
Johnson & Johnson reported 15 stocks worth $762M in its 13F filing for Q3 2026, filed Oct 26, 2026. Its largest holdings are PTGX (45.3%), NBTX (23.0%) and MGTX (9.6%). The table above lists every position in the filing (the top 10 without an account).
What did Johnson & Johnson buy and sell in Q3 2026?
Compared with Q2 2026: 0 new positions, 1 added to, 0 trimmed and 0 sold out.
When will Johnson & Johnson file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Johnson & Johnson's portfolio worth?
The Q3 2026 filing reports $762M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.